New Arthritis Drug Approved Exclusively for Cats

Monoclonal antibody significantly reduces joint pain.

You have probably heard of monoclonal antibodies as drugs that help fight COVID-19. Now, a monoclonal antibody developed strictly for relieving arthritis pain in cats has been approved by the Food and Drug Administration (FDA). Called Solensia (generic name frunevetmab injection), it is actually the first monoclonal antibody approved for use in any species other […]
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Tufts Catnip

Get the next year of TUFTS CATNIP for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 44%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access